Mr Makepeace faced five charges.
The first charge was that in 2022 Mr Makepeace was convicted at Scarborough Magistrates Court of assaulting by beating his ex-partner.
He was sentenced to a community order and a curfew order and was ordered to pay a £95 surcharge and £85 in costs.
It was alleged that the conviction rendered him unfit to practise as a veterinary surgeon.
The second was that in August 2022, Mr Makepeace submitted a character reference which purported to have been written by his ex-partner saying that they "still live happily together", when this was untrue. It was also alleged that the reference purported to have been signed by Mr Makepeace's ex-partner when he knew that was not the case.
The third charge alleged that Mr Makepeace had sent WhatsApp messages to his ex-partner which were offensive, insulting, abusive, threatening and/or intimidating.
The fourth charge was that was a repetition of the second.
The fifth and final charge was that in relation to charges 2 and 4, that Mr Makepeace’s conduct was misleading and/or dishonest; and that it is alleged that in relation to charges 2,3,4 and/or 5, whether individually or in any combination, that Mr Makepeace was guilty of disgraceful conduct in a professional respect.
The first charge was proven by virtue of a certified copy of the memorandum of an entry in the Magistrates’ Court register.
Mr Makepeace also admitted the facts of all the other charges, meaning they were found proven by admission.
In terms of the conviction, the Committee assessed the incident to be serious – the assault was prolonged, involved strangulation and biting which led to physical injuries, and involved a pursuit.
This was found by the Committee to bring the reputation of the profession into disrepute.
The Committee therefore found that the conviction rendered Mr Makepeace unfit to practise.
With regard to the remaining charges, the Committee found Mr Makepeace’s behaviour serious, saying that it showed a blatant and wilful disregard of the role of the RCVS and the systems that regulate the veterinary profession, and that his actions were intended to dishonestly subvert that process.
The Committee considered that his actions fell sufficiently below the standards expected in terms of honesty and integrity, as well as in terms of the behaviour expected of a registered professional.
All this constituted disgraceful conduct in a professional respect.
When making a decision on the appropriate sanction, the Committee took into account evidence from Mr Makepeace, two character witnesses, and a document bundle including evidence of training, continuing professional development (CPD) and other testimonials.
Aggravating factors taken into account were:
Mitigating factors taken into account were that Mr Makepeace made full admissions at the start of the hearing; he expressed remorse; was shown to be of previous good character; that there had been a significant lapse of time since his conviction; he had made subsequent efforts to avoid repetition of the behaviour which led to the conviction; the financial impact upon Mr Makepeace if he was prevented from being able to practise; and the testimonials.
Neil Slater, Chair of the Disciplinary Committee and speaking on its behalf, said: “The Committee’s view was that the demands of the public interest in this case were high, and in light of all of the circumstances, removal from the register was the only means of upholding the wider public interest, which includes the need to uphold proper standards of conduct and performance, and to maintain confidence in the profession and its regulation.
“The Committee therefore decided to direct that the respondent should be removed from the Register.
"In coming to this decision, the Committee carefully applied the principle of proportionality and took into account the impact of such a sanction on the respondent’s ability to practise his profession, as well as the financial impact upon him, taking into account his evidence in this regard.
“However, the Committee determined that the need to uphold the wider public interest outweighed the respondent’s interests in this respect.
"In light of the gravity of the conduct, and all of the factors taken into account, any lesser sanction would lack deterrent effect and would undermine public confidence in the profession and the regulatory process.
"Removal was the only appropriate and proportionate sanction.”
https://www.rcvs.org.uk/concerns/disciplinary-hearings
The affected batches are: IsoFlo 250 ml 58006XN, 60003XN, 59005XN, 60006XN, 61001XN, 60016XN, 60017XN, 61018XN, 61015XN, 61016XN, 61017XN, 6062216, 6062225, 6062226, 6062217, 6063738 and Isothesia 250ml 6062335, 6063318.
Manufacturer Zoetis says there were a small number of reports of veterinary surgeons having difficulty in re-sealing the bottles after initial opening as the thread on the screw cap had not been fully formed. This defect does not impact the safety and efficacy of the product for animal use but the concern was related to potential evaporation from opened bottles which did not re-seal fully when closed.
Veterinary surgeons are asked to return any unopened bottles to the wholesaler and dispose of any opened bottles in the usual way. They will be fully reimbursed for the stock.
Zoetis says it has already addressed this packaging issue at the manufacturing site so that new batches of the product are unaffected.
Practices requiring further information on the matter should call Zoetis Technical Services on 0845 300 8034.
Hill's says the new diet, which has been through three clinical trials over four years, contains nutrients to help strengthen the skin's natural barrier against environmental allergens and the Histaguard complex with bioactives and phytonutrients to help manage a dog's response to environmental allergens.
Prescription Diet Derm Complete also uses egg as its single intact animal protein source, which Hill's says avoids 96% of adverse food reactions1 and has shown the ability to dampen the inflammatory response in dogs and reduce itching.
Hill's says the new diet represents a real breakthrough, both because it simplifies treatment and because it's the first dietetic food for both adverse food reactions and environmental sensitivities.
Michael Unsworth, Hill’s Vet Affairs Manager, UK & Republic of Ireland said: "Supporting patients with skin sensitivities can be extremely challenging. Not only is it uncomfortable for the pet themselves, but it can cause a lot of distress for owners who just want to give their dogs a happy and healthy life. There can be a lot of pressure to find a quick, effective and affordable solution.
"Our new Prescription Diet Derm Complete is truly a ground-breaking product; the result of years of trials and clinical studies that has seen visible skin healing in dogs with AFR in as little as 21 days2 and not a single dog showing signs of recurrence after using the product.
"We’re thrilled to introduce this innovative, life-changing product to the market, to the benefit of dogs, dog-owners – and of course veterinary professionals - everywhere."
Accompanying the launch, there's a free webinar taking place at 7.30pm on Tuesday 23 February (tomorrow) for veterinary surgeons in which Sarah Warren BVetMed MSc (Clin. Onc.) CertVD MRCVS will look at the complex nature of canine allergic skin disease and the importance of individualised treatment plans. To register, visit: https://www.veterinarywebinars.com/hills/canine-dermatitis-hills/
For more information about Prescription Diet Derm Complete, contact your Hill’s representative.
Reference
Your tip could be clinical in nature (perhaps specific to a particular discipline, like cardiology or exotics), or to do with practice management, or dealing with clients, or HR, or, well, anything really.
To enter the competition, login to VetSurgeon.org and submit your tip in the forum, here.
Just before you press the button to post your tip, you might like to tick the box marked: "EMAIL ME REPLIES TO THIS POST" which appears immediately above the post button. That way, you'll get an email when someone else posts a tip.
Above each post in the forum, there is now a 'Thank You' link, which allows members to express their thanks for sharing something. The five tips that generate the largest number of 'thank yous' by the end of November will win the Amazon vouchers.
VetSurgeon.org is all about facilitating the sharing of knowledge, ideas and experience. So any tip entered into the competition will also be disseminated, together with the contributor's name, on other social media channels, such as Facebook, Twitter, Linkedin and if you include a photo, on Instagram.
VetSurgeon.org Arlo Guthrie said: "The competition is really designed to show off the new 'thank you' feature on VetSurgeon, which allows members to show their appreciation when someone shares something useful with their peers. In due course, we'll be running similar competitions for the most thanked photos and videos uploaded to our galleries. Watch this space."
The tool is available to all practices, free of charge.
The downloadable and printable guide chart, which has been created by a number of specialists, will help veterinary surgeons, nurses and receptionists to identify urgent, potentially urgent, non-urgent and delayable cases to help limited veterinary resources be used to best efficiency without compromise to animal health or welfare.
The chart, which can be printed and put on a practice wall or referred to as a webpage via a mobile phone or tablet, has a number of supporting resources produced by the same specialists.
Sue Paterson, BSAVA President, said: “During these exceptional and worrying times veterinary surgeons need as much practical help and support as possible.
"We are hugely grateful for the indefatigable support of an enthusiastic group of volunteers who have rapidly produced this triage tool, which we are now able to share. It should enable patient queries to be processed, reliably and efficiently, allowing for emergency patients to be seen as a matter of urgency, within the current government and RCVS guidelines."
The triage tool is free to download and share: https://www.bsava.com/TriageTool
BSAVA is working on a number of other initiatives to support veterinary professionals during the current crisis, including new guidance on obtaining consent remotely for veterinary treatment. for more information, visit: https://www.bsava.com/adviceforCOVID19
Fitzpatrick Referrals has announced the launch of a new cancer and soft tissue surgery referral service headed by Professor Nick Bacon (pictured right) and Dr Laurent Findji.
Professor Bacon and Dr Findji are American and European Board-Certified Surgeons respectively, with extensive experience in cancer care and soft tissue surgery innovation.
Professor Bacon joins the service directly from his post as Head of Oncology at the University of Florida, College of Veterinary Medicine. He will also take up the position of part-time Chair of Oncology at the new University of Surrey School of Veterinary Medicine.
Dr Findji joins the team from his prior role as director of the VRCC in Essex, bringing his expertise in cancer and soft tissue surgery advancements.
Professor Noel Fitzpatrick, founder of Fitzpatrick Referrals, said: "With these two eminent and globally recognised Specialists leading the new service, the UK will now be able to provide an innovative approach and comprehensive diagnosis, treatment, management and prognosis for all cancer and soft-tissue patients. The service will also be able to use the additional expertise available through the University of Surrey and both Specialists will be available for referring vets to discuss cases and to offer advice on the innovative treatment options available."
Professor Stuart Carmichael, the new service's director, said: "We would only introduce a service like this when we know it can provide the best options, the most comprehensive care and the highest level of expertise available. This is a referral service which will change the way that cancer patients are dealt with in the UK."
Noel added: "It's a testament to the reputation of Fitzpatrick Referrals and the University of Surrey, our partner in education, that we have been able to attract talents as great as Nick and Laurent. This is an exciting time not only for the hospital, but also for first-opinion practices throughout the UK who can avail of this world-class opportunity to offer a potentially life-saving service to their clients for their patients."
The service will operate initially from a self-contained clinic at the existing Fitzpatrick Referrals Orthopaedic + Neurology Hospital in Surrey and will be accepting patients from 1st October.
Merial has announced that its canine NSAID, Previcox, is now now uniquely licensed for the relief of pain and inflammation associated with dental surgery in dogs.
According to the company, an estimated 70% of dogs over 2 years of age may have some degree of periodontal disease1, and painful extraction of teeth is often necessary for the successful management of this condition.
Merial says that Previcox has been demonstrated to control the pain associated with dental surgery, in a double-blinded, controlled trial2 in which dogs underwent maxillary canine tooth extraction. The results showed that Previcox treatment significantly reduced pain scores post dental surgery, making it the only NSAID with a specific claim for relief of post-operative dental pain. Results of physical examination and blood testing also confirmed the peri-operative safety profile of Previcox, with no treatment-related adverse effects noted during the trial.
To find out more, contact your Merial Territory Manager on 0870 6000 123. For more information about Previcox visit www.previcoxfordogs.co.uk
References
1 Wiggs RB and Lobprise HB. Periodontology. In: Veterinary Dentistry, Principles and Practice. Philadelphia: Lippincott-Raven; 1997. p1872 Merial Internal data PR&D0116401.
Cosacthen contains 0.25 mg/ml of tetracosactide which had only previously been available as human-registered or compounded veterinary ‘special’ preparations meaning availability and cost could be unpredictable.
Tetracosactide is used in the ACTH stimulation test to assess the adrenocortical function of patients with endocrine diseases, such as Cushing’s and Addison’s.
Dechra Brand Manager Claire Morgan said: “As experts in endocrinology, we recognise that the testing involved in adrenal conditions can be a costly process for pet owners, which can mean that some cases don’t progress to treatment or have their treatment optimised.
"The launch of Cosacthen gives veterinary surgeons the reassurance associated with a veterinary licensed medicine. As these cases can appear on an irregular basis, Cosacthen is ideal to keep in the practice ready for when a case is presented making it a cost-effective solution that can help offset the cost for owners of long-term treatment of adrenal conditions."
Cosacthen is available in 1 ml single-use vials.
For more information visit www.dechra.co.uk/cosacthen.
Doxycare is a doxycycline indicated for the treatment of bacterial respiratory tract infections in cats and dogs due to organisms sensitive to doxycycline, and for the treatment of tick-borne Ehrlichia canis infection in dogs. Doxycare is presented in two strengths: 40mg and 200 mg. Both are licensed for use in cats and dogs. The meat-flavoured tablets are scored for quarter splitting to support more accurate dosing.
Metrocare is a metronidazole indicated for the treatment of gastrointestinal tract infections caused by Giardia spp. and Clostridia spp. and the treatment of infections of the urogenital tract, oral cavity, throat and skin caused by obligate anaerobic bacteria. Metrocare is available in two strengths: 250mg and 500 mg. Both are licensed for use in cats and dogs. The meat-flavoured tablets are scored for quarter splitting.
Cephacare, Animalcare’s first-generation cephalosporin, is now also available in a 1000 mg strength meat-flavoured tablet. Cephacare is licensed to treat skin infections, urinary tract infections, respiratory tract infections, digestive tract infections and infections of the oral cavity. The existing 50 mg strength tablet is licensed for use in cats and dogs. The new 1000 mg size tablets are scored to be halved and licensed for use in larger dogs.
James Beaumont, Product Manager, said: "We aim to offer our customers flexible and convenient solutions for the products they need to use every day in practice, while supporting more accurate and responsible dosing. The additions of Doxycare and Metrocare to our range, together with the new 1000 mg Cephacare strength tablet, mean that we are now able to offer a broader range of antibiotics for use in both cats and dogs."
NDSR’s European Specialist in neurology and neurosurgery Niklas Bergknut is performing the surgery.
He said: "This type of surgery for dogs is not performed in many clinics across the country.
"The pituitary gland is, of course, a very small gland which is very close to the brain, so it requires considerable expertise to perform the operation, followed by a lot of after-care to help the animal recover properly after surgery.
"The pituitary gland produces hormones which are essential for life, so it is then vital to constantly monitor the dog, its blood, hormones and fluid levels both during surgery and for a longer period after surgery.
"Although surgery may be challenging, the aftercare can be even more challenging and requires very skilled internal medicine specialists to manage the patients after surgery.
"Our medics and nurses carry out various blood tests and manage the fluid balance every hour after surgery and all the way through to the dog going home.
"Every department in the hospital has to work closely together to ensure the best possible treatment and the best possible outcome."
Niklas, who learned the technique from Bjorn Meij, Professor of Surgery at the University of Utrecht, described how the operation is performed. He said: "We go in through the mouth, up through the soft palate and into the underside of the cranium. Then you drill a little hole to access the tumour that way.
"It is obviously essential to make sure you are in exactly the right place or the outcome could be disastrous.
"It is also important to operate as early as possible before the tumour gets too big.
"Trying to remove a big tumour is more difficult and holds greater risks because of the damage that can be done to the surrounding brain in attempting to remove the tumour."
Niklas says that if surgery is successful, the results are impressive, with most dogs making a full recovery and not suffering any recurrence of the tumours, a better outcome than treating the dogs with traditional methods such as radiotherapy.
He added: "Removing the tumour like this is the only way of permanently treating tumours of this type. Radiotherapy is very good too but there is a much larger likelihood of the tumour growing back."
For more information, visit www.ndsr.co.uk.
The company says that CircoMax Myco offers the longest lasting combined protection on the EU market against PCV2 and M. hyopneumoniae pathogens. This reduces the PCV2 viral load in blood and lymphoid tissues, PCV2 fecal shedding, lymphoid tissue lesions associated with PCV2 infection, and lung lesions associated with M. hyopneumoniae infections.
Pig protection was demonstrated against porcine circovirus genotypes 2a, 2b and 2d and lasts for at least 23 weeks after vaccination in fattening pigs for both PCV2 and M. hyopneumoniae.
Monica Balasch, Director, Global Biologicals Development at Zoetis, said: "Porcine circovirus type 2 has demonstrated high mutation and recombination rates and is known to be rapidly evolving in Europe and worldwide. Commercial PCV2 vaccines have been efficacious in controlling the clinical disease, but there is a growing genetic gap between field viruses and vaccines. So far, all vaccines in Europe have been based on one single genotype, PCV2a, while today the most prevalent viruses found belong to other genotypes: PCV2b and especially PCV2d.
“We believe that there is a need for new vaccines, like CircoMax Myco which includes two PCV2 genotypes for a broader coverage. We found excellent results showing reduction of body weight gain losses in field trials in the EU. This innovative one-dose vaccine is a new tool for veterinarians and producers that may improve their PCV2 and M. hyopneumoniae control programs, especially in the face of multi-genotype PCV2 infections.”
Alvaro Aldaz, Director, Global Commercial Development, Swine, Zoetis, said: "For many years, intensive vaccination has contributed to selective pressure and emergence of new PCV2 genotypes. European pig farms are often infected with more than one genotype and subclinical disease is frequent. Commercial vaccines are all based on PCV2a genotype while CircoMax Myco is the first vaccine that includes two PCV2 genotypes (a & b), and the inventive M. hyopneumoniae purified fraction. It is formulated with MetaStim for active immunization, resulting in 23 weeks of protection against these threats."
CircoMax Myco contains inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2a open reading frame 2 (ORF2) protein, inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2b ORF2 protein and inactivated Mycoplasma hyopneumoniae, strain P-5722-3.
James qualified from Glasgow University in 2002 before joining Rosemullion Veterinary Practice, a mixed practice in Falmouth, Cornwall, of which he became a Director in 2008.
In 2014, Rosemullion separated its farm and small animal work, whereupon James became Clinical Director of the new farm practice, Coast2Coast Farm Vets.
In 2015, following the acquisition of Rosemullion and Coast2Coast by CVS, he was appointed to the group's Farm and Equine Clinical Advisory Committees. These Committees comprise clinical staff from across the Farm and Equine Divisions and make decisions on important issues, including purchasing, advice and information for its clinical teams and investments in the latest equipment and facilities.
James said: "I’ll be spending time each week travelling around the UK, Ireland and Holland to visit our farm practices and meet with colleagues within CVS and from the wider farming and veterinary industries.
"During my first six months, I’ll be focusing on developing frameworks and policies that will enable our practices to guide clients through difficult issues, such as antimicrobial and anthelmintic resistance and to help them succeed in the highly competitive marketplace for both prescription and non-prescription medicines.
"I will also be creating a bespoke farm New Graduate Programme for young vets which all our farm practices will be able to access.
"I see an exciting opportunity for CVS Farm to become a major force in the sector and am looking forward to working with my new colleagues to bring this about."
Vetswap was set up by Luke Ramsden and Euan McKee MsRCVS, two globe-trotting veterinary surgeons who saw the opportunity for colleagues in the profession to combine work and travel without losing the security of their long-term job.
As part of the partnership, VetSurgeon Jobs now includes a dedicated section for VetSwap which contains a link to job swap opportunities posted by the company.
VetSurgeon.org Editor Arlo Guthrie said: "Job swapping sounds like a great way to get a fresh-perspective and gain some CPD, not to mention a holiday in the sun.
"VetSwap is a natural fit with VetSurgeon Jobs, broadening the range of opportunities we can offer.
"On top of that, VetSurgeon.org exists to support veterinary surgeons, so when Euan and Luke contacted me, I was only too pleased to do what I can to try and give them a leg up."
VetSwap is now running a competition to win £200 worth of Amazon vouchers and a free VetSwap. All you have to do is visit their Facebook page and share this post with a colleague: https://www.facebook.com/VetSwapTM/videos/1881120178807211/
The charge against Dr Irvine was that in July 2017, he failed to discuss with the owners alternative treatment options to dental surgery under general anaesthetic, or the risks of dental surgery under general anaesthetic, and failed to obtain informed consent from the owners for the surgery.
Dr Vasilev was also originally charged with failing to discuss alternative treatment options or the risks of the surgery and failing to obtain informed consent. However, at the outset of the hearing, as a result of new information which came to light, the RCVS opted to offer no evidence in relation to these charges. Mr Vasilev was separately charged with failing to maintain clear, accurate and detailed clinical records in relation to his treatment of the dog.
At the outset of the hearing, Mr Irvine denied all aspects of the charge against him; while Dr Vasilev admitted all aspects of the remaining charge.
The Committee heard how Rupert's dental surgery under general anaesthetic was recommended by Mr Irvine on 10th July and performed by Dr Vasilev on 11th July 2017. After the surgery, Rupert was discharged, but vomited in his sleep that same night. He was brought back to the practice on 12th July, where Dr Vasilev administered antiemetic and antibiotic medication.
However, Rupert continued to vomit over the next five days, and was seen by the practice on 17th July and then on 18th when blood tests were conducted. Rupert’s condition deteriorated as he continued to vomit and lose weight and he was brought back to the practice on 22nd July where he was euthanased by Dr Vasilev.
The Committee heard evidence from Rupert’s owners as well as two expert witnesses. It found the first aspect of the charge against Mr Irvine proven on the basis that there was an inadequate discussion with the owners regarding the option of delaying the dental treatment on Rupert because of his recent ascites caused by congestive heart failure.
The Committee found the second aspect of the charge against Mr Irvine proven on the basis that he had not discussed the risks of Rupert undergoing general anaesthetic given the recent diagnosis of congestive heart failure, following which (in relation to the third aspect of the charge against Mr Irvine), it was therefore found proven that he had failed to gain informed consent.
With all aspects of the charge against Mr Irvine being proven, and with Dr Vasilev admitting the charge against him, the Committee went on to consider if the proven and admitted charges against both amounted to serious professional misconduct.
In respect of Mr Irvine, Stuart Drummond, chairing the Committee and speaking on its behalf, said: "The Committee was not persuaded that the failure to obtain informed consent from [the owner] and discuss matters further with her on 10th July 2017 in the circumstances of this case would amount to serious professional misconduct which would bring the profession into disrepute.
"In the Committee’s judgment, the breach of standards, whilst amounting to professional misconduct, was not serious professional misconduct, in the context of other discussions which had taken place…. The Committee further decided that a finding of serious professional misconduct in this case would be disproportionate having taken into consideration the discussions that Mr Irvine had with [the owner] prior to 10th July 2017 and the fact he was dealing with a complex and changing case.
"The Committee therefore found that Mr Irvine was not guilty of disgraceful conduct in a professional respect."
The Committee noted that Dr Vasilev had admitted breaching the Code of Professional Conduct for Veterinary Surgeons in respect of failing to keep adequate clinical and client records.
However, in mitigation, the Committee considered a number of factors including that, in failing to maintain adequate notes related to Rupert’s treatment, Dr Vasilev had followed the standard of notetaking in the practice as set out by Mr Irvine who was practice principal; that Dr Vasilev had only worked with Mr Irvine in the UK and his record-keeping was limited to working in one practice; that Dr Vasilev admitted his failures at an early stage of the proceedings; that he had made efforts to avoid repetition in the future by undertaking webinars and research; and, that he had shown insight into the need to ensure full communication and detailed note-taking.
Stuart Drummond added: "In relation to Dr Vasilev, the Committee was satisfied that [his] standard of record-keeping was in breach of the Code of Professional Conduct for Veterinary Surgeons and that the breach… amounted to professional misconduct.
"The Committee concluded that the breaches overall, when considering the context and number of mitigating factors, were, in the Committee’s view, insufficient to amount to serious professional misconduct…. Accordingly it found Dr Vasilev not guilty of disgraceful conduct in a professional respect."
The full facts and findings from the case can be found at www.rcvs.org.uk/disciplinary.
Mr Wood was convicted of three offences which involved the download of 38 videos and 13 indecent images of children, at Portsmouth Magistrates’ Court in December 2017.
In January 2018, he was sentenced to a three-year Community Sentence for each offence, to run concurrently, and was made subject to a five-year Sexual Harm Prevention Order.
He was also fined £1,000 and ordered to pay costs of £340 and a victim surcharge of £85.
Mr Wood was also placed on the barring list by the Disclosure and Barring Service and required to register with the police pursuant to the Sexual Offences Act 2003 for a period of five years.
Mr Wood appeared before the Disciplinary Committee, admitted his conviction and accepted that it rendered him unfit to practise veterinary surgery.
In determining the sanction, the Committee says it took into account a number of mitigating factors: his conviction involved no actual harm or risk of harm to an animal; there was no financial gain; he had engaged in open and frank admissions at an early stage; he was experiencing mental ill-health at the time of the offence; he had taken subsequent steps to avoid a repetition of such behaviour; there had been a significant lapse of time since the incident; and he showed insight into the harm caused by his offence.
The Committee also considered that the purpose of a sanction is not to punish, but to protect the welfare of animals, as well as maintain public confidence in the profession and declare and uphold proper standards of conduct. On consideration of the appropriate sanction, the Committee decided that postponement of judgement was not appropriate, and that taking no action was not an option.
The Committee then considered whether a reprimand or warning was appropriate, but they considered that would not match the gravity of the offence – a period of suspension would also mean Mr Wood would automatically return to the Register after the period of time without the College being able to review his fitness to practise, rendering it an inappropriate sanction. The Committee therefore determined that the removal of Mr Wood from the RCVS Register was the only way to protect the wider public interest and maintain confidence in the profession.
Ian Green, chairing the Committee and speaking on its behalf, said: "The Committee has not taken this decision lightly, and, lest it be misinterpreted, it has not taken it in order to satisfy any notional public demand for blame and punishment.
"It has taken the decision because in its perception, the reputation of the profession had to be at the forefront of its thinking and ultimately it was more important than the interests of the Respondent.
"The decision is not simply based on the fact that these offences were of a sexual nature but because they were repeated frequently over a significant period of time, and at the time, the Respondent knew on his own admission that what he was doing was wrong.
"Accordingly, the Committee had decided that removal from the Register is appropriate and proportionate in this case. The Committee will direct the Registrar to remove the Respondent’s name from the Register forthwith."
Mr Wood has 28 days to appeal the Committee’s decision after which, if no appeal is received, the Committee’s judgment takes effect.
The product is marketed in a 10ml pack and has an expiry date of December 2017. The batch number is 6231-90D.
The 1ml syringe within the pack has 'Lbs' printed as the unit of measure instead of kg, which could lead to an incorrect dose being administered to dogs.
Any queries about returning this product should be addressed to:
Mr Ken Allen Qualified Person and Quality Advisor E-mail: ken.allen@norbrook.co.ukTelephone: + 02830 264435
In 2020, BSAVA Congress will have been held at the ICC Birmingham for thirty years. However, recent years have seen ever greater competition from the London Vet Show, so the plan to revitalise the event further north at an award-winning new venue with such good transport links seems to make a lot of sense.
Manchester Central's size also means that unlike in Birmingham, the commercial exhibition, lectures and demonstrations will all take place under one roof, maximising the use of delegates' time.
Angharad Belcher, Head of BSAVA Congress said: "We’ve had a first-class experience in Birmingham, and we could not have asked for more from the venue. We know that 2019 and 2020 will continue to be popular, however, it’s time to move BSAVA Congress forward and revitalise the offering to our delegates and exhibitors by bringing everything into one building. The move to Manchester enables us to invest even more in speakers and delegate experiences, to make BSAVA’s education programme truly unsurpassable."
BSAVA President Philip Lhermette said: "It’s very much a new city for a new Congress and celebrations will be in order. Manchester lends itself perfectly to a timely transformation for Congress. We will be completely re-branding the event, modernising the CPD programme and making the best possible use of every minute of every delegate’s time over the full four days. We have been working closely with the city and venue in practical terms to offer a whole suite of options to delegates and exhibitors, from irresistible new socials and extensive accommodation choices, to easy transport routes."
Shaun Hinds, CEO of Manchester Central said: "After getting to know the association and their vision, it was clear that they wanted to transform the experience of their delegates. The ambition of the association matches that of the city and Manchester has the perfect blend of venue and vibrancy to develop the BSAVA Congress of the future. We’re delighted to be welcoming them in 2021 and we’ll work hard with the organisers to create a unique and remarkable experience for their delegates, exhibitors, partners and all visitors."
The survey, which this year had a record 1605 respondents, covers everything from basic earnings, bonuses and dividends to benefits such as accommodation, car allowance and pensions.
The survey found that the median salary package for all vets in 2021 was £48,325; £3000 more than in 2020.
For all nurses the median package was £24,227 in 2021 and for head nurses the figure rose to £31,013.
The median daily rate for a locum vet was £350 in 2021, a rise of over 16% since 2020.
The hourly locum rate increased by 36% to £41 per hour.
Similarly, locum nurse daily rates have risen by over 30% since 2020 to £144 and their hourly rate increased by 14% to £20.
New grad vets' salary packages actually dropped by £800 in 2021, to £32,700.
However, the 2021 new grad hourly rate increased to £15.66 from £15.04 in 2020.
SPVS says this could indicate that newly qualified vets are earning less because they are working, on average, three hours less a week.
This may suggest that they are prioritising their work life balance, with time off being more important than an overall salary.
SPVS also highlights a growing gender gap in salary.
81% of the respondents were female, and the median full time salary difference between men and women was 21%, compared to 15% in 2020.
SPVS hypothesises that this could be because there are more male vets in more senior positions, rather than because of gender per se.
The question, therefore, is why there are more male vets than females in senior positions.
The survey showed very similar numbers of males and females doing both clinical and non-clinical post graduate training. But more than twice as many men than women go on to take up positions of leadership or seniority, or in referrals.
More research is needed to understand why females are doing the extra training, but apparently not using it to further their career.
As in 2020 SPVS has also looked at satisfaction with remuneration, hours worked, conditions, support and prospects and is using this data to create a separate report which will be available soon.
For more information, visit: https://spvs.org.uk/spvs-survey/
'Potential role of veterinary flea products in widespread pesticide contamination of English rivers1, was carried out by Professor Dave Goulson and Rosemary Perkins MRCVS from the University of Sussex and co-authored by Martin (pictured right) and Wayne Civil from the Environment Agency.
For the study, they looked at 3,861 samples taken from 20 rivers around the UK between 2016 and 2018. Fipronil was detected in 98% of the samples and imidacloprid in 66%.
Currently, there are no environmental quality standards for fipronil or the compounds it breaks down into (fipronil sulfone or fipronil sulfide) or for imidacloprid in British surface waters.
The authors therefore used the acute and chronic toxicity limits for fipronil from a report from the Department of Environmental Toxicology at the University of California Davis2, and from Morissey et al (2015)3 for imidacloprid.
They found that the average fipronil concentration across the rivers sampled by the Environment Agency exceeded chronic safety thresholds five-fold. The overall pollution levels in English rivers indicate that fipronil and its toxic breakdown products pose a high risk to aquatic ecosystems.
While, in most rivers, imidacloprid was found to pose a moderate risk, in seven out of the 20 rivers sampled there was a high environmental risk.
The paper, published in Science of the Total Environment, noted that the highest levels of pollution were found immediately downstream of wastewater treatment works, which the authors say supports the hypothesis that significant quantities of pesticide may be passing from treated pets to the environment via household drains.
Professor Dave Goulson said “Fipronil and imidacloprid are both highly toxic to all insects and other aquatic invertebrates. Studies have shown both pesticides to be associated with declines in the abundance of aquatic invertebrate communities. The finding that our rivers are routinely and chronically contaminated with both of these chemicals and mixtures of their toxic breakdown products is deeply troubling.”
Bathing of pets treated with spot-on fipronil flea products has been confirmed as a potentially important route to waterways for fipronil via sewers. The washing of hands, pet bedding or other surfaces that have come into contact with treated pets are potential additional pathways for entry to sewers.
Rosemary said: “We’ve identified a number of steps that can be taken to minimise or avoid environmental harm from pet flea and/or tick treatments. These range from introducing stricter prescription-only regulations, to considering a more judicious and risk-based approach to the control of parasites in pets, for example by moving away from blanket year-round prophylactic use."
Martin said: "The profession urgently needs to adopt ‘responsible use of parasiticides’ similar to the way it is adopting responsible use of antimicrobials. The VMD needs to strengthen the environmental assessment of pet pesticide products in the authorisation process, and they are currently considering this issue. The VMD should also collate and publish annual sales figures for these pesticides as they do for antimicrobials."
He added: "My veterinary hospital has never had a ‘pet health plan’ to provide year round flea products, because we believe that year-round, intensive treatment for almost all dogs and cats does not constitute responsible use of such powerful pesticides."
Morrissey, C.A., et al., 2015. Neonicotinoid contamination of global surface waters and associated risk to aquatic invertebrates: a review. Environ. Int. 74, 291–303. https://doi.org/10.1016/j.envint.2014.10.024.
The company says it thinks the film is an industry first because it depicts veterinary professionals in a way that they have never seen themselves before: cinematically showing the highs and lows of a typical day in veterinary practice.
Vets4Pets also says it wants the film to generate greater recognition for everyone working within the industry, not just its own staff, by showcasing the passion, dedication and commitment that unites them.
Keith Leonard MRCVS, Practice Owner at Vets4Pets Leeds Birstall where some of the video was filmed, said: “While there are no words that can do justice to the sheer passion and determination demonstrated by the entire veterinary community, taking part in this campaign and seeing the result is really emotional.
“After an unimaginably turbulent few years, this campaign makes me feel incredibly proud of my whole team.
"It genuinely shows what it’s like to work in veterinary practice and I can’t thank each and every one of my team enough for their outstanding dedication to the care of our clients – both the pets we care for and their owners.
"We all live and breathe what we do, and I hope they feel a sense of pride when they see this campaign.”
Gordon Dunn, People Director at Vets4Pets, said: “The veterinary sector has experienced immense pressure following years of unprecedented challenges and as an industry we need to do our utmost to ensure that veterinary professionals are supported in their development and careers. But alongside this, we need to understand that recognition goes a long way too.
VetSurgeon member Alex Gough MRCVS, Head of Medicine Referrals at Bath Veterinary Referrals, has published his second historical thriller, Bandits of Rome, available for pre-order now in paperback (£7.99) or Kindle (£1.99) from Amazon.
The book picks up the story of Gaius Valerius Carbo as he leaves Rome with his family for the Italian countryside, only to be set upon by masked bandits.
Alex's first thriller, Watchmen of Rome, went to the top of the Amazon bestseller charts and has achieved reader reviews of an average 4.4 out of 5 stars.
Apparently the more people that pre-order the book before the 26th August, the higher it'll go up the charts. So if this sounds like it could be up your street, buy it today and you'll give a colleague a helping hand up the ladder at the same time.
A survey published today by the veterinary recruitment agency recruit4vets has found 45.8% of salaried veterinary surgeons earning less than £35K per annum.
251 veterinary surgeons in full-time permanent employment took part in the survey, the largest number (37%) working in the south east and London.
The survey found that the typical starting salary was £31K per annum, rising to 41K for a more experienced vet in small animal practice, and £44K for more experienced large animal practitioners. The survey also found that senior vets with over 20 years experience earn up to £69K.
The survey also looked at locum charge-out rates, which varied from £220-£230 per day (17%) to over £250 (15%), with the greatest number (29%) charging between £240-£250.
62% of locums said their hourly pay rate had not changed in the last 12 months, compared to 45% of permanent staff who said their salary was unchanged over the period. This despite 65% of vets saying that the demands on them within the practice had increased in the last 12 months.
Recruit4vets has produced a couple of video presentations about the results, locum pay covered here and permanent pay covered here.
Visit VetSurgeon.org Jobs for the largest selection of classified jobs for veterinary surgeons.
Founded by Peter Rossdale in Newmarket in 1959, the practice now boasts a team of 50 veterinary surgeons and has established an international reputation for providing world class ambulatory, referral and laboratory services. The team is led by RCVS, European and American recognised veterinary specialists and operates from four sites in Newmarket, Exning, Hertfordshire and Lambourn.
Each year, Rossdales Equine Hospital in Exning hosts a large number of CPD courses which often include internationally recognised guest speakers who lecture alongside Rossdales’ specialist clinicians, with delegates attending from as far afield as Europe, Singapore, Dubai and Australia.
To celebrate the practice’s Diamond anniversary, Rossdales is hosting a special 'Diamond Series' of CPD events in 2019 in addition to its usual programme of educational courses.
Mike Shepherd, Managing Partner at Rossdales, said: "Since the practice was established by Peter Rossdale in 1959, it has always prided itself on clinical research and the willing distribution of this and other information to the veterinary profession. This ‘Diamond Anniversary’ series of CPD events is an initiative that we hope will benefit many of our veterinary colleagues. The first of these special events, the Diamond Series Veterinary Nursing Congress, was held at the beginning of June and was fully subscribed. We’re very pleased by the excellent feedback it generated."
Two further ‘Diamond Series’ events are scheduled, for veterinary surgeons and veterinary students respectively:
The Diamond Series Veterinary Surgeons Congress takes place on Friday,12th and Saturday, 13th July 2019 and is for all veterinary surgeons with an interest in equine or mixed practice. The programme covers a wide area of subjects, with talks provided by 12 veterinary surgeons from Rossdales Equine Hospital and Rossdales Laboratories. It also includes admission to The Moët & Chandon July Festival at Newmarket Racecourse on Saturday, 13th July.
The Diamond Series Undergraduate Congress will take place on Saturday, 10th and Sunday, 11th August 2019. This course is aimed at all current veterinary undergraduates who want to gain more knowledge and experience in the fields of equine veterinary medicine and surgery. There will be talks and presentations from 9 veterinary surgeons from Rossdales Equine Practice, Rossdales Equine Hospital and Rossdales Laboratories. There will also be a course dinner on the Saturday evening.
For more information, visit www.rossdales.com/news-events.
The poster grades faeces from one (kickable) to six (most certainly not kickable).
James Kyffin, Veterinary Director at Protexin Veterinary said: "We believe that Poop Points offers pet owners a fun and engaging way to monitor their pet’s faeces."
That, surely, must win James the "Oxymoronic Veterinary Quote of the Year Award 2019".
More seriously, he went on to say: "It is important to raise awareness of alterations in animal’s faecal scores and ensure that this is communicated to their veterinary surgeon in an effective way."
Practices in the UK and Ireland can order their free poster on Protexin's website: https://www.protexinvet.com/pooppoints, or by emailing info@protexin.com.
Protexin will also be promoting digestive health advice on its website and social channels (@Protexin Veterinary on Facebook and Instagram), which practices can share and use.
During the four-day hearing, the Committee heard evidence in respect of three separate heads of charge brought against Mr Shah following a castration operation conducted on Shadow, a six-year old Newfoundland dog, which took place on 20 June 2014.
The three charges were as follows:
There was no complaint made as to the undertaking of the operation itself, and the Committee followed the advice from the Legal Assessor that each charge should be considered separately. When making its decision, the Committee did not take into account the fact that Shadow had died as it is impossible to say whether he would have survived had Mr Shah acted differently.
The Committee found each of the allegations against Mr Shah proved. In respect of the first charge the Committee heard from two expert witnesses, Professor Williams and Mr Plumley, who agreed that the decision to discharge Shadow at about 6pm on 20 June 2014, given his condition, was inappropriate.
The Committee considers that discharging Shadow at that time into the care of the owner given his state on discharge, was grossly negligent and a serious error of judgement. It therefore found Mr Shah to be guilty of the first charge.
The Committee then considered that, after being alerted to Shadow’s continued lack of progress by the telephone call from Gemma Ballantyne between 30 and 45 minutes after discharge, Mr Shah exacerbated the situation by the inadequacy of his response in dealing with the concerns raised which, in the Committee’s view, represented a continuation of his previous poor judgement.
The Committee considered that Mr Shah was under a duty of care to advise Gemma Ballantyne to seek urgent veterinary attention for Shadow and by his own admission he failed to do so, and he was therefore found guilty of the second charge.
During that telephone call Mr Shah also gave no further details about the out-of-hours care available to Gemma Ballantyne other than to inform her that there would be an additional cost.
He did not seek confirmation that any such information been supplied by his colleague, Emma Martin (who at the relevant time was a student nurse), however, and at no time did he see Gemma Ballantyne in possession of the discharge sheet. The Committee therefore found Mr Shah guilty of this final head of charge.
The Committee did accept that there was no element of dishonesty, nor was there an aim of financial gain in the case. The Committee also considered that Mr Shah was acting in good faith at all times. It also accepted that Mr Shah was entitled to assume that normal practice had been followed and that a previously compiled discharge sheet, containing the number of the out-of-hours provider, had been supplied to Miss Ballantyne.
Ian Green, chairing the Committee and speaking on its behalf, said: "Balancing all of the factors as the Committee must, it is clear that on this occasion Mr Shah’s conduct fell far short of that which is expected and it therefore finds he conducted himself disgracefully in a professional respect."
Mr Green added: "In imposing the sanction of a reprimand, the Committee urges Mr Shah in the strongest possible terms to ensure that his future conduct by way of training and support systems within his practice are such as to avoid any possibility of a future incident such as this occurring in order to ensure animal welfare and public confidence in the veterinary profession. The Committee notes that in her evidence, Emma Martin said that the working practices at the surgery have been changed and the Committee expects that all animals kept in the care of Mr Shah are fully monitored, examined and assessed in relation to their condition before being discharged."